Obesity in pregnancy
However, the therapeutic ceiling of GLP-1 monotherapy, along with the heterogeneous nature of obesity, has highlighted the significance of developing more potent agents, engaging multiple nutrient-stimulated hormone (NUSH) pathways [7]
Among the main findings of the research, we highlight that the supplements of greatest clinical relevance in the treatment of PCOS are characterized by being aimed at the progressive improvement of the most frequent clinical manifestations in patients, thus encompassing four important parameters to achieve an efficient result: glycemic control, dyslipidemia control, reduction of oxidative stress, and hormonal control (Figure 1)
Semaglutide produces gradual and steady improvements that build consistently over time
10.1172/JCI200318797 175 Van Den BoschL.Van DammeP.BogaertE.RobberechtW
GLP-1 agonists are drugs that mimic the action of GLP-1 hormone in our body